May 20, 2022
Japan’s key health ministry panel will discuss whether to put forward a package of medicines for approval at its upcoming meeting on June 2 including Sanofi’s anti-C1s monoclonal antibody sutimlimab. The Pharmaceutical Affairs and Food Sanitation Council’s (PAFSC) first Committee...read more